5-Amino-1MQ vs AOD-9604 (and MOTS-c): Research Comparison

5-Amino-1MQ vs AOD-9604 and 5-amino-1MQ vs MOTS-c are common comparison searches in metabolic research, but the three compounds are not even the same kind of molecule. 5-Amino-1MQ is a small-molecule enzyme inhibitor, AOD-9604 is a modified fragment of growth hormone, and MOTS-c is a peptide encoded in mitochondrial DNA. Each is a different entry point into metabolic research models. This guide compares them by mechanism and covers why 5-amino-1MQ and MOTS-c are studied together. For in-vitro laboratory research only.

5-Amino-1MQ vs AOD-9604 vs MOTS-c at a glance

• Class: small-molecule NNMT inhibitor (5-amino-1MQ); modified growth-hormone fragment (AOD-9604); mitochondrial-derived peptide (MOTS-c)
• Chemistry: a quinolinium cation with no amino-acid backbone; a synthetic peptide modeled on the C-terminal 176-191 region of human growth hormone; a 16-residue peptide encoded in mitochondrial DNA
• Core readouts: NAD+ salvage and the SAM-to-SAH ratio; lipolysis and fat-metabolism markers; AMPK activation and glucose handling
• Typical models: cultured adipocytes and high-fat-diet rodents; adipocyte lipolysis and rodent fat-metabolism models; skeletal-muscle cells and rodent metabolic models

What is 5-amino-1MQ? An enzyme inhibitor

5-Amino-1MQ (5-amino-1-methylquinolinium) is a small heterocyclic molecule, not a peptide, described in the medicinal-chemistry literature as a selective inhibitor of nicotinamide N-methyltransferase (NNMT). NNMT uses S-adenosylmethionine (SAM), the cell's main methyl donor, to methylate nicotinamide, producing 1-methylnicotinamide and S-adenosylhomocysteine (SAH). Because nicotinamide is also what cells recycle into NAD+, NNMT sits at the junction of NAD+ salvage and methyl-donor balance. Research asks what happens to both pools when the enzyme is inhibited, mostly in adipocyte and rodent models. The full background is in What Is 5-Amino-1MQ?.

What is AOD-9604? A growth-hormone fragment

AOD-9604 is a synthetic peptide modeled, in modified form, on the C-terminal 176-191 region of human growth hormone (GH), the segment associated with GH's activity on lipid metabolism. It was developed to study that activity apart from the rest of the hormone, and the published literature characterizes it as not acting through the GH receptor and not raising IGF-1. Research centers on lipolysis (the breakdown of stored lipids) in adipocyte and rodent models. See What Is AOD-9604?, and AOD-9604 vs tesamorelin for its comparison with a peptide acting upstream on the GH axis.

What is MOTS-c? A mitochondrial signaling peptide

MOTS-c is a 16-residue peptide encoded in the 12S rRNA region of the mitochondrial genome, one of a small group of mitochondrial-derived peptides. It was first characterized in 2015 as a regulator of metabolic homeostasis in cell models and mice, with skeletal muscle as a principal target tissue. That work linked it to AMPK, the cell's central energy sensor, via the folate pathway and the accumulation of AICAR, an endogenous AMPK activator. Later cell studies reported that MOTS-c moves into the nucleus under metabolic stress. See What Is MOTS-c?.

5-Amino-1MQ vs AOD-9604: enzyme inhibitor vs growth-hormone fragment

Both turn up in adipocyte research, but they reach the fat cell from different directions. 5-Amino-1MQ acts on an intracellular enzyme, so its readouts are biochemical: NAD+ levels, the SAM-to-SAH ratio and, further downstream, lipid-synthesis (lipogenesis) pathways. AOD-9604 models one slice of a hormone's activity, so its readouts center on lipolysis. IGF-1 makes a useful control readout in AOD-9604 models, since the fragment is characterized as not raising it.

5-Amino-1MQ or AOD-9604: which fits a given study?

It depends on the variable under study. For how NAD+ availability or methyl-donor balance shapes adipocyte metabolism, 5-amino-1MQ is the relevant tool. For whether lipid-metabolism signaling can be separated from GH-receptor and IGF-1 activity, AOD-9604 is the more direct probe. As parallel arms of one adipocyte model, the two contrast an enzyme route with a hormone-fragment route into the same cell.

5-Amino-1MQ vs MOTS-c: enzyme inhibitor vs mitochondrial signal

This is the closer comparison. Neither compound is a receptor agonist; both are studied as intracellular regulators of energy metabolism. They differ in where they act and what they read out:

• Site of action: cytosolic NNMT (5-amino-1MQ) vs a signal encoded in mitochondrial DNA (MOTS-c)
• Core readouts: NAD+ and SAM levels vs AMPK activation and glucose handling
• Model emphasis: adipocyte and liver-cell models vs skeletal-muscle models

MOTS-c vs 5-amino-1MQ in energy-sensing research

The two pathways are connected. AMPK and the NAD+-dependent sirtuins are studied as linked energy-sensing systems, so a lab examining one often measures the other: 5-amino-1MQ shifts the NAD+ side by reducing a drain on nicotinamide, while MOTS-c engages the AMPK side. A second point of contact is less obvious. The folate pathway MOTS-c was reported to act through is part of one-carbon metabolism, the network that supplies the methyl groups SAM carries and NNMT consumes.

5-Amino-1MQ and MOTS-c: why they are studied together

Searches for "5-amino-1MQ and MOTS-c" frame the pair as a combination as often as a comparison. The rationale is that they approach cellular energy metabolism from two sides: the NAD+ cofactor supply and the AMPK energy sensor. A design that runs 5-amino-1MQ alone, MOTS-c alone and both together can ask whether the two routes converge on the same readouts; only the single-compound arms let a lab attribute a change to one compound or to their interaction. This guide makes no claim about how the two behave in combination; that is what a controlled design is built to find out.

Adding NAD+ to the comparison

Some searches add NAD+. NAD+ is the coenzyme itself, so in a design it serves as a direct reference for the pool that NNMT inhibition is studied for preserving. Pre-mixed combinations fix the ratio between compounds; separate solutions let each be varied alone. See What Is NAD+? and the mitochondrial and cellular energy research peptides collection.

Three entry points into metabolic research models

• An enzyme: 5-amino-1MQ inhibits NNMT, changing how nicotinamide and SAM are spent inside the cell
• A hormone fragment: AOD-9604 models a lipid-metabolism-related slice of GH activity, without the GH receptor or IGF-1
• A mitochondrial signal: MOTS-c is encoded in mitochondrial DNA and studied through AMPK

None ranks above the others; the right reference compound follows from the pathway a study names. The wider map is in best research peptides for metabolic studies and the Weight Loss Research Peptides collection.

Handling and reconstitution

All three ship lyophilized from our US facility with tracking and are reconstituted with bacteriostatic water before in-vitro use; the technique in how to reconstitute peptides applies to a lyophilized small molecule such as 5-amino-1MQ too. Molecular weights differ widely, so record concentration per compound: the 5-amino-1MQ calculator, AOD-9604 calculator and MOTS-c calculator return it for each vial size. Order 5-Amino-1MQ, AOD-9604, MOTS-c or NAD+ directly.